Physician profile
Tamara James
NPI 1366468423
$648.99
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $26.19 · 2021: $17.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $142.48 | 2019-2021 | |
| Avanos Medical | $125.94 | 2019 | |
| Astellas Pharma US INC | $90.09 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $55.26 | 2019 | |
| Avion Pharmaceuticals | $41.55 | 2019-2020 | |
| Therapeuticsmd, INC. | $39.27 | 2019 | |
| Duchesnay USA Incorporated | $27.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.70 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.24 | 2019 | |
| Coopersurgical, INC. | $15.03 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.24 | 2019 | |
| Pfizer INC. | $13.49 | 2019 | |
| Novo Nordisk INC | $13.26 | 2019 | |
| Radius Health, INC. | $12.59 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.